BriaCell Therapeutics Corp. (BCTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 27.14K | 26.39K | 36.43K | 27.46K | 26.05K | 26.12K | 71.85K | 3.76K | 3.84K | 3.73K | 3.86K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -27.14K | -26.39K | -36.43K | -27.46K | -26.05K | -26.12K | -71.85K | -3.76K | -3.84K | -3.73K | -3.86K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 100% | -4.2% | -1.03% | 49.3% | -630.76% | -577.95% | -599.68% | -1760.89% | 1.47% | 0.62% | -0.16% | - |
| Operating Expenses | 7.62M | 7.64M | 11.67M | 11.65M | 8.74M | 10.57M | 7.17M | 8.01M | 12.61M | 13.21M | 11.69M | 10.29M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.65M | 2.02M | 2.3M | 1.94M | 2.1M | 2.19M | 2.07M | 1.89M | 2.15M | 2.11M | 2.26M | 3.39M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 5.97M | 8.26M | 9.37M | 9.72M | 6.65M | 8.38M | 5.1M | 6.12M | 10.46M | 11.1M | 9.43M | 6.9M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | -7.67M | -11.67M | -11.69M | -8.74M | -10.57M | -7.17M | -8.01M | -12.61M | -13.21M | -11.69M | -10.29M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 100% | 27.43% | -62.63% | -45.99% | 30.68% | 20.03% | 38.64% | 22.19% | -63.07% | -120.33% | -59.4% | -89.88% |
| EBITDA | 0 | -7.64M | -11.63M | -11.65M | -8.71M | -10.53M | -7.14M | -7.91M | -12.61M | -13.21M | -11.68M | -10.29M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 100% | 27.42% | -62.95% | -47.39% | 30.94% | 20.29% | 38.93% | 23.13% | -63.11% | -120.43% | -59.44% | -89.96% |
| D&A (Non-Cash Add-back) | 0 | 27.14K | 37.36K | 36.43K | 36.83K | 39.29K | 37.11K | 100.57K | 5.21K | 5.13K | 5.25K | 5.1K |
| EBIT | 0 | -7.67M | -11.67M | -11.69M | -8.55M | -10.57M | -7.17M | -8.01M | 2.31M | -13.21M | -11.69M | -3.23M |
| Net Interest Income | 0 | 146.78K | 48K | 45.7K | -14.72K | 67.46K | 17.8K | 0 | 21.01K | 110.31K | 256.63K | 278.87K |
| Interest Income | 0 | 146.78K | 48K | 45.7K | 37.89K | 67.46K | 17.8K | 0 | 21.01K | 110.31K | 256.63K | 278.87K |
| Interest Expense | 0 | 0 | 0 | 0 | 52.61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 0 | 238.63K | 62.53K | 533.18K | 103.33K | 1.23M | -941.61K | 4.52M | 14.93M | -2.02M | 19.88M | 7.06M |
| Pretax Income | -7.16M | -7.43M | -11.6M | -11.16M | -8.6M | -9.34M | -8.11M | -1.73M | 2.31M | -15.23M | 8.19M | -3.23M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -7.16M | -7.35M | -11.49M | -11.06M | -8.46M | -9.27M | -8.08M | -1.69M | 2.34M | -15.18M | 8.25M | -3.23M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 15.36% | 20.7% | -42.25% | -556.01% | -461.03% | 38.93% | -197.89% | 47.82% | 135.15% | 4.41% | 649.36% | 84.01% |
| Net Income (Continuing) | -7.16M | -7.43M | -11.6M | -11.16M | -8.6M | -9.34M | -8.11M | -1.73M | 2.31M | -15.23M | 8.19M | -3.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -649.1K | -698.28K | -627.56K | -751.79K | -654.96K | -554.19K | -458.83K | -419.97K | -366.14K | -328.54K | -281.99K | 0 |
| EPS (Diluted) | -0.99 | -2.62 | -4.35 | -5.87 | -1.64 | -22.77 | 0.17 | -10.02 | 21.68 | -10.64 | -7.50 | -22.85 |
| EPS Growth % | 39.63% | 88.49% | -2658.82% | 41.42% | -107.56% | -114% | 102.27% | 56.15% | 551.67% | 7.88% | -614.29% | -4563.27% |
| EPS (Basic) | -0.99 | -2.62 | -4.35 | -5.87 | -1.64 | 11.15 | 0.17 | 2.87 | 21.68 | -10.64 | 5.70 | -22.50 |
| Diluted Shares Outstanding | 7.25M | 2.8M | 1.88M | 1.88M | 1.87M | 2.7M | 1.78M | 1.2M | 1.07M | 1.07M | 1.11M | 1.07M |
| Basic Shares Outstanding | 7.25M | 2.8M | 1.88M | 1.88M | 1.87M | 2.7M | 1.78M | 1.2M | 1.07M | 1.07M | 1.07M | 1.07M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |